Organon & Co | OGN - Operating Expenses

Stock Price
8.15
Daily Change
-0.05 -0.61%
Monthly
9.54%
Yearly
-45.45%
Q1 Forecast
8.28

Organon & Co reported $906M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
Celltrion KRW 724.99B 6B Sep/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Divis Laboratories Ltd INR 19.4B 1.47B Sep/2025
Gilead Sciences USD 4.26B 95M Sep/2025
Glaxosmithkline GBP 7.77B 2.22B Sep/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 10.02M 9.78M Jun/2025
Merck USD 10.72B 1.28B Sep/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Novartis USD 9.77B 401M Sep/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Organon & Co USD 906M 362M Sep/2025
Pharma Mar EUR 39.62M 7.34M Sep/2025
Qiagen NV USD 395.29M 2.28M Sep/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025